Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other neoplasm 1Other hematologic neoplasm 1Myeloid 1CNS 1

Conditions

Leukemia, Myeloid, Acute 540Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Hematologic Neoplasms 266Leukemia 179Myelodysplastic Syndromes 170Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma 102Lymphoma, Non-Hodgkin 94Recurrence 86Neoplasms 84Multiple Myeloma 81Leukemia, Myelogenous, Chronic, BCR-ABL Positive 71Leukemia, Myelomonocytic, Chronic 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Burkitt Lymphoma 54Leukemia, Biphenotypic, Acute 48Myeloproliferative Disorders 45Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 42Hodgkin Disease 34Lymphoma, B-Cell 32Lymphoma, B-Cell, Marginal Zone 30Leukemia, B-Cell 30Anemia, Refractory, with Excess of Blasts 30Primary Myelofibrosis 27Leukemia, Plasma Cell 23Waldenstrom Macroglobulinemia 22Neoplasm, Residual 22Leukemia, Myeloid, Chronic-Phase 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Pathologic Processes × Other hematologic neoplasm × Clear all
NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Orca Biosystems, Inc.

Phase 2 Recruiting
80 enrolled
MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡